Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
You can scan, snap a photo, speak, search, or quick-add a meal, then see protein, fiber, and water beside the weight trend instead of juggling several tools
Key Takeaway Prescription weight loss medications have come a long way
Tirzepatide Research# SURPASS program (Type 2 diabetes): Five Phase 3 trials demonstrating superior HbA1c reduction compared to insulin glargine, semaglutide, and insulin degludec SURMOUNT program (Obesity): Phase 3 trials showing up to 20.9% weight loss at 72 weeks FDA approvals : Mounjaro (May 2022) for T2D
Finally, you create an account and complete a final round of health history questions to determine whether you qualify
At present, the therapeutic application and potential value of GLP-1RAs in diseases other than diabetes has become a research hotspot
Where Injected GLP-1 Therapies Still Lead Weekly injections such as Wegovy and Mounjaro remain ahead in: Higher average long-term weight-loss percentages More established long-term safety data Real-world evidence across large patient populations Because injections have been studied for over a decade, they currently hold the strongest clinical outcomes in obesity care
US$ 20.72
US$ 22.65
US$ 20.06
